Literature DB >> 1375552

Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials.

G Holl1, M Straschill, T Thomsen, J P Fischer, H Kewitz.   

Abstract

The action of galanthamine (GAL), a cholinesterase inhibiting substance, on resting EEG and on flash visual evoked potentials (VEPs) was tested in 9 healthy subjects. Alpha power was increased significantly in 4 of 8 subjects after the infusion of 10 mg, which provided a median inhibition of 47% of acetylcholinesterase in erythrocytes. Mean alpha frequency and peak alpha frequency decreased significantly in 5 of the 8 subjects by 0.22-0.98 Hz. Alpha power increase and alpha frequency decrease were not accompanied by changes in theta power. The amplitudes of the late components of the flash VEP were increased in 8 of 9 subjects receiving doses of 10-35 mg of GAL, while the early components remained unaffected. Increase of late VEP components was significantly correlated with the strength of cholinesterase inhibition. The synchronizing effect of GAL in these healthy volunteers obviously contrasts with the known desynchronizing effect of physostigmine in animal experiments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375552     DOI: 10.1016/0013-4694(92)90050-r

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  6 in total

1.  The effects of physostigmine on the response characteristics of the cat visual evoked potential.

Authors:  G Rubboli; K Arakawa; G G Celesia; N S Peachey; H Tomoda
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 2.  Galantamine: a review of its use in Alzheimer's disease.

Authors:  L J Scott; K L Goa
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 3.  Galanthamine.

Authors:  B Fulton; P Benfield
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

4.  Galanthamine in Alzheimer's disease : a new alternative to tacrine?

Authors:  M Rainer
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

5.  Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease.

Authors:  Kamila Krasodomska; Wojciech Lubiński; Andrzej Potemkowski; Krystyna Honczarenko
Journal:  Doc Ophthalmol       Date:  2010-06-13       Impact factor: 2.379

6.  TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.

Authors:  Emi Kurimoto; Masato Nakashima; Haruhide Kimura; Motohisa Suzuki
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.